Epilepsy Trial, Recruiting (NCT06550726)

Epilepsy Trial, Recruiting NCT06550726 Sponsor: Chinese University of Hong Kong Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT06550726 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with focal epilepsy (a type of epilepsy that starts in one specific area of the brain) that has not responded to medication, where at least two of the following point to the same area of the brain: the pattern of seizures, brainwave testing (EEG), or a type of brain scan taken during a seizure (SPECT-CT).
People who have previously had at least one MRI brain scan using a detailed epilepsy-specific scanning method, where that scan did not find a visible cause for the epilepsy.
People who are able to give written consent to have an MRI scan. For people under 18 years old, a parent or guardian may provide consent on their behalf.

Who may not be able to join:

People who have metal implants or other conditions that make having an MRI scan unsafe or not recommended.
People who are unable to stay still or cooperate during an MRI scan.
People who are unable to give informed consent to participate in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hanson Leung, MBBS (HK), Chinese University of Hong Kong

Phone: 35051009

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06550726

Sponsor: Chinese University of Hong Kong

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 35051009

More information: https://clinicaltrials.gov/study/NCT06550726

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with focal epilepsy (a type of epilepsy that starts in one specific area of the brain) that has not responded to medication, where at least two of the following point to the same area of the brain: the pattern of seizures, brainwave testing (EEG), or a type of brain scan taken during a seizure (SPECT-CT).
People who have previously had at least one MRI brain scan using a detailed epilepsy-specific scanning method, where that scan did not find a visible cause for the epilepsy.
People who are able to give written consent to have an MRI scan. For people under 18 years old, a parent or guardian may provide consent on their behalf.

Who may not be able to join:

People who have metal implants or other conditions that make having an MRI scan unsafe or not recommended.
People who are unable to stay still or cooperate during an MRI scan.
People who are unable to give informed consent to participate in the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chinese University of Hong Kong

Registry

ClinicalTrials.gov

Start date

1 September 2024

Est. completion

31 August 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

Accuracy of high resolution MRI in diagnosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov